The first stop for professional medicines advice

Risperidone

Published
Topics: CCG commissioned new medicinesMental health and illnessNew Medicines · Patent expiriesPre-registration new medicines (UK/EU)RisperidoneSafety in BreastfeedingStability in dosette boxesStability outside the fridge ·
Contents
  1. dm+d
  2. Refrigerated Storage
    1. Risperdal Consta · Janssen-Cilag Ltd
  3. Medicine Compliance Aid Stability
    1. generic · Consilient Health Ltd
    2. generic · Accord Healthcare Ltd
  4. Lactation Safety Information
    1. Oral
    2. Depot injection

dm+d

108386000

Refrigerated Storage

Risperdal ConstaJanssen-Cilag Ltd

Janssen-Cilag Ltd
Risperdal Consta
25mg/ 37.5mg / 50 mg powder and solvent for prolonged-release suspension for intramuscular injection

In the event of an inadvertent temperature excursion the following data may be used:
If refrigeration is unavailable, Risperdal Consta can be stored at temperatures not exceeding 25°C for no more than 7 days prior to administration.

Please also refer to the manufacturer’s product literature for recommended storage information at https://www.medicines.org.uk

Contact Janssen-Cilag Ltd in cases where additional stability data is required. Refer to the current BNF for company contact details.

Yes - reduce to 7 days from date of excursion as above
29 October 2021
London MI Service

Medicine Compliance Aid Stability

genericConsilient Health Ltd

Consilient Health Ltd
generic
Tablets orodispersible 3mg, 4mg
R2 · Red 2Drug is not suitable for CAs due to theoretical reasons that cannot be mitigated.
Unsuitable
Orodispersible tablet therefore hygroscopic
2 November 2022
Usage of Medicines in Compliance Aids

genericAccord Healthcare Ltd

Accord Healthcare Ltd
generic
Tablets f/c 0.5mg, 1mg, 2mg, 3mg, 6mg
A3 · Amber 3No stability data is available. There are theoretical concerns with use in CAs, which may be mitigated by risk minimisation.
Protect from light
Protect from light
22 November 2022
Usage of Medicines in Compliance Aids

Lactation Safety Information

Oral

Oral
Caution
Quetiapine, Haloperidol
Limited evidence that maternal oral doses up to 6mg daily produce low levels in milk
Long half-life of active metabolite increases risk of accumulation in breastfed infants
Monitor infant for sedation, poor feeding, behavioural effects, extrapyramidal symptoms, and developmental milestones
Safety in Lactation: Antipsychotics
22 January 2020
Bibliography

Depot injection

Depot injection
Caution
No published evidence of safety for use as depot injection. However maternal oral doses of up to 6mg daily produce low levels in milk
Long half-life of active metabolite increases risk of accumulation in breastfed infants
Monitor infant for sedation, poor feeding, behavioural effects, extrapyramidal symptoms, and developmental milestones
Safety in Lactation: Antipsychotics
22 January 2020
Bibliography